Long-Term Efficacy of Certolizumab Pegol Dosed at 400 Mg Every Two Weeks in Patients With Plaque Psoriasis: Pooled 128-Week Data from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2). J of Skin 2019, 3, S36. https://doi.org/10.25251/skin.3.supp.36.